Next Article in Journal
Transcriptome Comparison Reveals Key Components of Nuptial Plumage Coloration in Crested Ibis
Next Article in Special Issue
High NRF2 Levels Correlate with Poor Prognosis in Colorectal Cancer Patients and with Sensitivity to the Kinase Inhibitor AT9283 In Vitro
Previous Article in Journal
The Arg/N-Degron Pathway—A Potential Running Back in Fine-Tuning the Inflammatory Response?
Previous Article in Special Issue
The NRF2/KEAP1 Axis in the Regulation of Tumor Metabolism: Mechanisms and Therapeutic Perspectives
Review

NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases

1
Unidad de Química Orgánica y Farmacéutica, Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense, 28040 Madrid, Spain
2
Instituto Teófilo Hernando y Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, 28029 Madrid, Spain
3
Instituto de Investigación Sanitaria, Servicio de Farmacología Clínica, Hospital Universitario de la Princesa, 28006 Madrid, Spain
*
Author to whom correspondence should be addressed.
Biomolecules 2020, 10(6), 904; https://doi.org/10.3390/biom10060904
Received: 6 May 2020 / Revised: 3 June 2020 / Accepted: 9 June 2020 / Published: 14 June 2020
NRF2 acts by controlling gene expression, being the master regulator of the Phase II antioxidant response, and also being key to the control of neuroinflammation. NRF2 activity is regulated at several levels, including protein degradation by the proteasome, transcription, and post-transcription. The purpose of this review is to offer a concise and critical overview of the main mechanisms of NRF2 regulation and their actual or potential use as targets for the treatment of neurodegenerative diseases. View Full-Text
Keywords: NRF2–ARE pathway; neurodegenerative diseases; oxidative stress; KEAP1; NRF2 regulation NRF2–ARE pathway; neurodegenerative diseases; oxidative stress; KEAP1; NRF2 regulation
Show Figures

Figure 1

MDPI and ACS Style

Cores, Á.; Piquero, M.; Villacampa, M.; León, R.; Menéndez, J.C. NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases. Biomolecules 2020, 10, 904. https://doi.org/10.3390/biom10060904

AMA Style

Cores Á, Piquero M, Villacampa M, León R, Menéndez JC. NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases. Biomolecules. 2020; 10(6):904. https://doi.org/10.3390/biom10060904

Chicago/Turabian Style

Cores, Ángel, Marta Piquero, Mercedes Villacampa, Rafael León, and J. C. Menéndez 2020. "NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases" Biomolecules 10, no. 6: 904. https://doi.org/10.3390/biom10060904

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop